Late onset myasthenia: 34 cases in patients over 65;La myasthenie de revelation tardive: 34 cas chez des patients de plus de 65 ans

Revue Neurologique

Volumn 153, Issue 2, 1997, Pages 129-134

  Bille Turc F ^a   Padovani, R ^b   Pouget, J ^a   Serratrice, G ^b   Bille J ^a  

^a HÔPITAL SAINT JOSEPH   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMBENONIUM; AZATHIOPRINE; CHOLINESTERASE INHIBITOR; IMMUNOGLOBULIN G; NEOSTIGMINE; PREDNISONE; PYRIDOSTIGMINE;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYASTHENIA; AGING; MYASTHENIA GRAVIS; RETROSPECTIVE STUDY; REVIEW;

AGED; AGED, 80 AND OVER; AGING; HUMANS; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES;

EID: 0030910824     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. ALUIN H., GOULON M., BENTUE-FERRER D. (1985). Médicaments de la myasthénie et des syndromes myasthéniques. Sem Hop Paris, 61,11 : 707-722.
2. BARTON E.N., MORGAN O.S., SMIKLE M.F., MONTGOMERY I., SPENCER H., SIVAPRAGASAM S. (1991). Myasthenia gravis in Jamaïca. Clinical, immunological and genetic studies. West Indian Medical Journal, 40, 4 : 162-166.
3. CHRISTENSEN P.B., JENSEN T.S., TSIROPOULOS I., SORENSEN T., KJAER M., HOJER-PEDERSEN E., RASMUSSEN M.J.K., LEHFELDT E., DE FINE OLIVARIUS B. (1993). Incidence and prevalence of myasthenia gravis in western Denmark : 1975 to 1989. Neurology, 43:1779-1783.
4. COSI V., ClTTERlO A., LOMBARDI M., PlCCOLO G., ROMANI A., ERBETTA A. (1991). Effectiveness of steroid treatment in myasthenia gravis : a retrospective study. Acta Neurol Scand, 84, 1 : 33-39.
5. DEVATHASAN G., KUEH Y.K., CHONG P.N. (1984). High dose intravenous gammaglobulin for myasthenia gravis. Lancet, II, 8106 : 809-810.
6. DONALDSON D.H., ANSHER M., HORAN S., RUTHERFORD R.B., RINGEL S.P. (1990). The relationship of age to outcome in myasthenia gravis. Neurology, 40:786-790.
7. ELCHIDIAC A., LEPAGE V., BERRIH S., COLOMBANI J., DEGOS L. (1985). HLA et myasthénie. Subdivision en trois catégories. Sem Hôp Paris (Paris), 61, 25 :1821-1825.
8. FERRARI G., LOVASTE M.G. (1992). Epidemiology of myasthenia gravis in the province of Trento (northern Italy). Neuroepidemiology, 77,3:135-142.
9. GAMONDES J.P., BALAWI A., GREENLAND T., ADLEINE P., MORNEX J.F., ZHANG J., MARET G. (1991). Seventeen years of surgical treatment of thymoma : factors influencing survival. European Journal of Cardio-Thoracic Surgery, 5, 3 :124-131.
10. GENKINS G., KORNFELD P., PAPATESTAS A.E., BENDER A.M., MATTA R. (1987). Clinical experience in more than 2000 patients with myasthenia gravis. Ann NY Acad Sci, 505 :500-513.
11. GOULON M., GAJDOS P., GOULON-GOEAU C. (1987). La myasthénie, modèle de maladie par auto-anticorps. Ann Med Interne, 138,6 : 444-461.
12. HOHFELD R., MICHELS M., HE'ININGER K., BESINGER U.A., TOYKA K.V. (1988). Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis. Neurology, 38:258-261.
13. MATELL G. (1987). Immunosuppressive drugs : Azathioprine in the treatment of myasthenia gravis. Ann NY Acad Sci, 505 : 588-594.
14. MANTEGAZZA R., ANTOZZI C., PELUCCHETTI D., SGHIRLANZONI A., CORNELIO F. (1988). Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol, 235:449-453.
15. MIANO M.A., BOSLEYT.M., HEIMAN-PATTERSONT.D., REED J., SERGOTT B.C., SAVINO P.J., SCHATZ N.J. (1991). Factors influencing outcome of prednisone dose reduction in myasthenia gravis. Neurology, 41 .-919-921.
16. OLANOW C.W., WECHSLER A.S., ROSES A.D. (1982). A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis. Ann Surg, 196:113-121.
17. OOSTERHUIS H. (1984). Myasthenia gravis. Churchill Livingstone, Edinburgh.
18. PAPATESTAS A.E., GENKINS G., HOROWITZ S.H., KORNFELD P. (1976). Thymectomy in myasthenia gravis : pathologic, clinical, and electrophysiologic correlations. Ann NY Acad Sci, 274 :555-573.
19. PHILLIPS L.H., TORNER J.C., ANDERSON M.S., COX G.M. (1992). The epidemiology of myasthenia gravis in central and western Virginia. Neurology, 42:1888-1893.
20. SGHIRLANZONI A., PELUCHETTI D., MANTEGAZZA R., FIACCHINO F., CORNELIO F. (1984). Myasthenia gravis : prolonged treatment with steroids. Neurology, 34, 2 :170-174.
21. TOYKA K.V., HOHFELD R., BESINGER U.A., GERHOLD B., HEININGER K. (1985). Myasthenia gravis ; Reactivation of clinical disease and autoimmune factors after discontinuation of long-term azathioprine. Ann Neurol, 17:238-242.
22. TURANI E., SZATHMARY I., MOLNAR J., SZOBOR A. (1993). Myasthenia gravis : prognostic significance of clinical data in the prediction of post-thymectomy respiratory crises. Acta Chirurgica Hungarica, 33, 3-4 : 353-360.
23. VERMA P.K., OGER J.J.F. (1992). Seronegative generalized myasthenia gravis : low frequency of thymic pathology. Neurology, 42:586-589.
24. Yu L, HAWKINS B.R., IP M.S., WONG V., WOO E. (1992). Myasthenia gravis in Hong Kong Chinese 1 - Epidemiology and adult disease. Acta Neurol Scand, 86, 2:113-119.